Correlation Between Milestone Pharmaceuticals and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Alzamend Neuro, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Alzamend Neuro.
Diversification Opportunities for Milestone Pharmaceuticals and Alzamend Neuro
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Alzamend is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Alzamend Neuro
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.03 times more return on investment than Alzamend Neuro. However, Milestone Pharmaceuticals is 1.03 times more volatile than Alzamend Neuro. It trades about 0.16 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.18 per unit of risk. If you would invest 152.00 in Milestone Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 33.00 from holding Milestone Pharmaceuticals or generate 21.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 97.67% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Alzamend Neuro
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Alzamend Neuro |
Milestone Pharmaceuticals and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Alzamend Neuro
The main advantage of trading using opposite Milestone Pharmaceuticals and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.The idea behind Milestone Pharmaceuticals and Alzamend Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Alzamend Neuro vs. Solid Biosciences LLC | Alzamend Neuro vs. Kezar Life Sciences | Alzamend Neuro vs. Senti Biosciences | Alzamend Neuro vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |